Third Annual Bloom Burton & Co. Healthcare Investor Conference Confirmed

Third Annual Bloom Burton & Co. Healthcare Investor Conference Confirmed

Healthcare companies and investors to meet in Toronto on June 17 and 18, 2014

Toronto, Ontario / CNW / April 7, 2014

Bloom Burton & Co., a firm dedicated to accelerating returns in healthcare (“Bloom Burton” or the “Company”), confirmed today the third annual Bloom Burton & Co. Healthcare Investor Conference (“BBHIC”) will take place at the Toronto Board of Trade on June 17 and 18, 2014.

The event attracts Canadian, U.S. and international investors who are interested in the latest developments from Canadian healthcare companies. Attendees will have the opportunity to obtain corporate updates from public and private companies, while institutional investors will be able to schedule private, one-on-one meetings with companies. Bloom Burton will also host a series of panel discussions, keynote speakers and networking events at the conference.

On June 17, Bloom Burton will host a special event, the Bloom Burton & Co. Pre-Venture Symposium to showcase approximately a dozen of Canada’s most promising pre-venture companies in the healthcare sector. The Bloom Burton Healthcare Investor Conference takes place the following day on June 18 to showcase 36 of Canada’s premier publiclytraded and venture-backed private companies. Registration for all events is complimentary for professional investors, pharmaceutical business development executives and members of the media. The conference agenda, company presentation list and registration details can be found at www.bloomburton.com/conference.

Bloom Burton’s CEO, Jolyon Burton commented, “a core aspect of our firm’s unique methodology is to act as a hub for the broader healthcare industry in Canada. For the third year in a row, we will bring hundreds of healthcare investors, innovators and community members to Toronto to network, learn and discuss important topics in healthcare investing. We also wish to thank our event gold sponsors for their generous support: Baker & McKenzie LLP, BDO Canada, Ernst & Young LLP, McCarthy Tetrault LLP and Troutman Sanders LLP.”

About Bloom Burton & Co.

Bloom Burton & Co. is a firm dedicated to accelerating monetization for both investors and companies alike in the healthcare sector. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in reaching the appropriate monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and product development consulting and also create and incubate new biotechnology and healthcare companies. Please visit www.bloomburton.com to learn more.

For more information, please contact: